Search results
Results from the WOW.Com Content Network
Novo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in Clayton, North Carolina, in a bid to boost the supply of its blockbuster weight loss drug Wegovy ...
In the town of Clayton, Novo Nordisk plans to build an additional 1.4 million square feet of production space, about twice the size of the company’s three existing North Carolina manufacturing ...
In 2015, the Danish drugmaker Novo Nordisk announced plans to double its facility space in Johnston County with a $1.85 billion investment, then the largest manufacturing commitment in state history.
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, [3] with production facilities in nine countries and affiliates or offices in five. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28% of its shares and a majority (77%) of its voting shares. [4]
Obesity drug-maker Novo Nordisk will spend $4.1 billion to build a U.S. facility to fill injection pens for its hugely popular weight-loss treatment Wegovy and diabetes drug Ozempic, it said on ...
The entrance to one of Novo Nordisk’s two manufacturing facilities in Clayton, North Carolina on June 24, 2024. ... which five years ago announced it would create more than 1,600 jobs at a new ...
Novo Nordisk's CEO took a $1.5 million pay cut in 2024 as the pharma giant's share price tanked and it missed profit and DEI targets. As U.S. firms scrap diversity targets, the CEO behind Ozempic ...
Catalent's plant in Bloomington, Indiana, will fill injection pens for Novo Nordisk's weight-loss drug Wegovy as part of the two companies' expanded supply agreement, two sources familiar with the ...